Clinical Trials
2 trialsNCT02030860 2025-07-25
A Study of Neoadjuvant Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT01357525 2021-11-24
SBRT for Close or Positive Margins After Resection of Pancreatic Adenocarcinoma
University of Pittsburgh
Phase NA Completed